Gt Medical Technologies, Inc.
Clinical trials sponsored by Gt Medical Technologies, Inc., explained in plain language.
-
Brain tumor breakthrough? GammaTile radiation added to standard care in new trial
Disease control OngoingThis study tests whether adding a special radiation tile (GammaTile) during brain surgery for newly diagnosed glioblastoma is safe and practical when followed by standard chemotherapy and radiation. About 61 adults will receive the tile at the time of tumor removal, then continue…
Phase: PHASE4 • Sponsor: GT Medical Technologies, Inc. • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
Brain tumor patients get radiation during surgery in new trial
Disease control OngoingThis study tests a new way to deliver radiation to the brain right after tumor removal, using a special tile called GammaTile. It compares this to the usual approach of waiting 3-4 weeks after surgery for standard radiation. The trial includes 230 adults with 1 to 6 new brain met…
Phase: PHASE3 • Sponsor: GT Medical Technologies, Inc. • Aim: Disease control
Last updated May 22, 2026 13:51 UTC